Literature DB >> 7533771

Lack of stimulation of 24-hour growth hormone release by hypocaloric diet in obesity.

M H Rasmussen1, A Juul, L L Kjems, N E Skakkebaek, J Hilsted.   

Abstract

Obesity is associated with a marked reduction in the spontaneous secretion of GH. To investigate the effect of acute alterations in calorie intake on GH release, 24-hr spontaneous GH release was measured during habitual calorie intake as well as during a short term, very low calorie diet (VLCD) in 6 obese subjects, 5 obese subjects after weight loss, and 5 normal, age- and sex-matched control subjects. Integrated 20-min samples were obtained over 24-h on two occasions in each subject using a constant blood withdrawal technique. In addition, basal levels of serum insulin-like growth factor-I (IGF-I), IGF-binding protein-1 (IGFBP-1), IGF-binding protein-3 (IGFBP-3), insulin, pro-insulin, and blood glucose were measured during habitual energy intake as well as during the hypocaloric diet. Twenty-four-hour GH release profiles and IGFBP-1 were decreased, and insulin as well as proinsulin levels were elevated in obese subjects compared to those in normal age- and sex-matched controls. No differences between obese subjects and normal controls were present regarding IGF-I, IGFBP-3, or IGF-I/IGFBP-3 molar ratio. In the last 24 h during the 96-h VLCD, an increase in 24-h GH release and basal IGFBP-1 levels and a decrease in basal insulin levels occurred in the normal controls, whereas no such changes were observed in the obese subjects. After caloric restriction 24-hr GH release, IGFBP-1 levels and insulin levels were similar in control subjects and obese subjects after weight loss. This suggests a reversible defect in GH release, rather than a persistent preexisting disorder. It is hypothesized that enhanced bioavailability of IGF-I, acting in concert with elevated proinsulin and insulin levels, may account for the lack of stimulation of 24-hr GH release by the hypocaloric diet in obese subjects. We conclude that the increase in 24-h spontaneous GH release and IGFBP-1 levels observed in normal subjects during the last 24 h of a 96-h VLCD is abolished in obese subjects. The lack of short term hypocaloric stimulation of spontaneous GH release may promote the retention of body fat and perpetuate the obese state.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7533771     DOI: 10.1210/jcem.80.3.7533771

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  Serum insulin-like growth factor-1 concentrations are reduced in severely obese women and raise after weight loss induced by laparoscopic adjustable gastric banding.

Authors:  Giulia Galli; Aldo Pinchera; Paolo Piaggi; Paola Fierabracci; Monica Giannetti; Giorgia Querci; Giovanni Scartabelli; Luca Manetti; Giovanni Ceccarini; Silvia Martinelli; Claudio Di Salvo; Marco Anselmino; Fausto Bogazzi; Alberto Landi; Paolo Vitti; Margherita Maffei; Ferruccio Santini
Journal:  Obes Surg       Date:  2012-08       Impact factor: 4.129

2.  Changes in plasma levels of ghrelin, leptin, and other hormonal and metabolic parameters following standardized breakfast, lunch, and physical exercise before and after a multidisciplinary weight-reduction intervention in obese adolescents.

Authors:  A E Rigamonti; F Agosti; A De Col; N Marazzi; C L Lafortuna; S G Cella; E E Muller; A Sartorio
Journal:  J Endocrinol Invest       Date:  2010-03-25       Impact factor: 4.256

3.  Hypothalamic leptin gene therapy reduces body weight without accelerating age-related bone loss.

Authors:  Russell T Turner; Michael Dube; Adam J Branscum; Carmen P Wong; Dawn A Olson; Xiaoying Zhong; Mercedes F Kweh; Iske V Larkin; Thomas J Wronski; Clifford J Rosen; Satya P Kalra; Urszula T Iwaniec
Journal:  J Endocrinol       Date:  2015-10-20       Impact factor: 4.286

4.  Differences in the GH-IGF-I axis in children of different weight and fitness status.

Authors:  Peter A Hosick; Robert G McMurray; A C Hackney; Claudio L Battaglini; Terry P Combs; Joanne S Harrell
Journal:  Growth Horm IGF Res       Date:  2012-03-20       Impact factor: 2.372

5.  Basal growth hormone concentration increased following a weight loss focused dietary intervention in older overweight and obese women.

Authors:  G D Miller; B J Nicklas; C C Davis; C Legault; S P Messier
Journal:  J Nutr Health Aging       Date:  2012-02       Impact factor: 4.075

6.  Growth-hormone response to combined stimulation with GHRH plus GH-releasing peptide-6 in obese patients with polycystic ovary syndrome before and after short-term fasting.

Authors:  D Micić; M Sumarac-Dumanović; Dj Macut; A Kendereski; S Zoric; V Popović; G Cvijović; C Dieguez; F F Casanueva
Journal:  J Endocrinol Invest       Date:  2003-04       Impact factor: 4.256

7.  Targeted deletion of growth hormone (GH) receptor in macrophage reveals novel osteopontin-mediated effects of GH on glucose homeostasis and insulin sensitivity in diet-induced obesity.

Authors:  Chunxia Lu; P Anil Kumar; Jinhong Sun; Anjali Aggarwal; Yong Fan; Mark A Sperling; Carey N Lumeng; Ram K Menon
Journal:  J Biol Chem       Date:  2013-04-17       Impact factor: 5.157

8.  IGF-1 gene polymorphism in obese patients with insulin resistance.

Authors:  Guzin Fidan Yaylali; Fulya Akin; Sabahat Turgut; Raziye Kursunluoglu
Journal:  Mol Biol Rep       Date:  2009-08-13       Impact factor: 2.316

9.  Targeted loss of GHR signaling in mouse skeletal muscle protects against high-fat diet-induced metabolic deterioration.

Authors:  Archana Vijayakumar; YingJie Wu; Hui Sun; Xiaosong Li; Zuha Jeddy; Chengyu Liu; Gary J Schwartz; Shoshana Yakar; Derek LeRoith
Journal:  Diabetes       Date:  2012-01       Impact factor: 9.461

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.